The aim of this study was to determine the effect of low and moderate doses of caffeine ingestion via caffeinated coffee on repeated sprint test (RST) and plasma catecholamine concentration in trained female team-sport athletes. In a randomized, double-blind, crossover design, 13 female team-sport athletes (VO_2max: 48.7 ± 4 mL·kg·min⁻¹) completed three RST trials, separated by 4-day, 60 min post-ingestion of either 3 mg·kg⁻¹ (LCOF) or 6 mg·kg⁻¹ (MCOF) or placebo (PLA). The RST consisted of 12 × 4 s sprints on a cycle ergometer interspersed with 20 s of active recovery. Blood lactate (BLa) and glucose (GLU) and epinephrine and norepinephrine concentrations were collected before and 60 min after coffee ingestion, and after RST. Heart rate (HR) and ratings of perceived exertion (RPE) were measured at the beginning of RST, and after the 6th and 12th sprints. Average peak power score during RST was significantly improved after LCOF (p = 0.016) and MCOF (p = 0.041) compared to PLA, but peak and mean power output of the individual sprints, and fatigue index were not different between trials (all p > 0.05). Epinephrine and norepinephrine concentrations were significantly higher before and after RST in LCOF and MCOF compared to PLA (all p < 0.05). BLa was also higher after RST in both LCOF and MCOF compared to PLA (p = 0.005). HR, RPE, and GLU were not different between conditions (p > 0.05). In conclusion, low and moderate dose of caffeine ingestion can enhance the average peak power score during repeated sprints. These findings partly support low and moderate doses of caffeine supplementation via coffee as a nutritional ergogenic aid for trained female team-sport players during repeated sprint exercise.

Purpose: Dietary nitrate supplementation has been reported to improve performance in kayaking and rowing exercise, which mandate significant recruitment of the upper-body musculature. Because the effect of dietary nitrate supplementation on swimming performance is unclear, the purpose of this study was to assess the effect of dietary nitrate supplementation on 100-m and 200-m swimming freestyle time-trial (TT) performance. Methods: In a double-blind, randomized crossover design, 10 moderately trained swimmers underwent 2 separate 3-d supplementation periods, with a daily dose of either 140 mL nitrate-rich (∼800 mg/d nitrate) or nitrate-depleted (PLA) beetroot juice (BRJ). After blood sampling on day 3, the swimmers performed both 200-m and 100-m freestyle swimming TTs, with 30 min recovery between trials. Results: Plasma nitrite concentration was greater after BRJ relative to PLA consumption (432 [203] nmol/L, 111 [56] nmol/L, respectively, P = .001). Systolic blood pressure was lowered after BRJ compared with PLA supplementation (114 [10], 120 [10] mm Hg, respectively P = .001), but time to complete the 200-m (BRJ 152.6 [14.1] s, PLA 152.5 [14.1] s) and 100-m (BRJ 69.5 [7.2] s, PLA 69.4 [7.4] s) freestyle swimming TTs was not different between BRJ and PLA (P > .05). Conclusions: Although 3 d of BRJ supplementation increased plasma nitrite concentration and lowered blood pressure, it did not improve 100-m and 200-m swimming TT performance. These results do not support an ergogenic effect of nitrate supplementation in moderately trained swimmers, at least for 100-m and 200-m freestyle swimming performance.

Nitrate (NO₃⁻) supplementation has been reported to enhance intermittent exercise performance; however, its impact on oxygen (O₂) cost during intermittent running exercise is unclear. The aim of this study was to assess if acute NO₃⁻ supplementation would elicit performance benefits in recreationally active individuals during the Yo–Yo intermittent recovery level 1 (Yo-Yo IR1) test, with its potential benefit on O₂ consumption (VO₂), in a double-blind, randomized, crossover study, 12 recreational males consumed NO₃⁻-rich (NIT; ~12.8 mmol), and NO₃⁻-depleted (PLA; 0.04 mmol) concentrated beetroot juice 3 h before completing the Yo-Yo IR1 test. VO₂ was measured at 160, 280 and 440 m (sub-maximal) and when the test was terminated (peak). Performance in the Yo–Yo IR1 was greater with NIT (990 ± 442.25 m) compared to PLA (870 ± 357.4 m, p = 0.007). The VO₂ was not significantly different at 160 m (1.92 ± 0.99 vs. 2.1 ± 0.88 L·min⁻¹), 280 m (2.62 ± 0.94 vs. 2.83 ± 0.94 L·min⁻¹), 440 m (3.26 ± 1.04 vs. 3.46 ± 0.98 L·min⁻¹) and peak (4.71 ± 1.01 vs. 4.92 ± 1.17 L·min⁻¹) between NIT and PLA trials (all p > 0.05). The present study has indicated that acute supplementation of NO₃⁻ enhanced intermittent running performance but had no effect on VO₂ during the Yo–Yo IR1 test in recreational young adults.

Purpose: To systematically review the current literature and meta-analyze the effects of dietary nitrate (NO₃⁻) supplementation on the contractile properties of skeletal muscle. Method: A literature search of three databases was conducted in June 2021, with 19 studies meeting the inclusion criteria. Studies were included if a placebo versus dietary NO₃⁻-only supplementation protocol was used in healthy human, assessed muscle contraction or activities that was < 3 minutes in duration and focused on the lower-body. For the meta-analysis, a pooled standardized mean difference (SMD) was determined for maximum voluntary contraction (MVC) (n = 11), cycling, running and inertial load squad peak power output (PPO) (n = 8), mean power output (MPO) (n = 6) and time to PPO (n = 4). Results: NO₃⁻ supplementation demonstrated a small improvement in PPO (SMD = 0.25, P = 0.030) and MPO (SMD = 0.28, P = 0.034) when compared to the placebo. NO₃⁻ also resulted in an enhanced time to PPO (SMD = −0.78, P < 0.001). There was no clear effect of NO₃⁻ on isometric MVC (SMD = 0.03, P = 0.758). Conclusion: This review reports that NO₃⁻ supplementation may have potential to enhance PPO, MPO and time to PPO during dynamic exercise, which may transfer to brief explosive actions commonly observed in sporting activities. Due to the variability in studies, we encourage researchers to use this work to explore areas where evidence in lacking and standardize the study design and procedures.

Background: Nitrate (NO₃⁻) supplementation has been reported to lower motor unit (MU) firing rate (MUFR) during dynamic resistance exercise; however, its impact on MU activity during isometric and ischemic exercise is unknown. Purpose: To assess the effect of NO₃⁻ supplementation on knee extensor MU activities during brief isometric contractions and a 3 min sustained contraction with blood flow restriction (BFR). Methods: Sixteen healthy active young adults (six females) completed two trials in a randomized, double-blind, crossover design. Trials were preceded by 5 days of either NO₃⁻ (NIT) or placebo (PLA) supplementation. Intramuscular electromyography was used to determine the M. vastus lateralis MU potential (MUP) size, MUFR and near fibre (NF) jiggle (a measure of neuromuscular stability) during brief (20 s) isometric contractions at 25% maximal strength and throughout a 3 min sustained BFR isometric contraction. Results: Plasma nitrite (NO₂⁻) concentration was elevated after NIT compared to PLA (475 ± 93 vs. 198 ± 46 nmol L⁻¹, p < 0.001). While changes in MUP area, NF jiggle and MUFR were similar between NIT and PLA trials (all p > 0.05), MUP duration was shorter with NIT compared to PLA during brief isometric contractions and the sustained ischemic contraction (p < 0.01). In addition, mean MUP duration, MUP area and NF jiggle increased, and MUFR decreased over the 3 min sustained BFR isometric contraction for both conditions (all p < 0.05). Conclusions: These findings provide insight into the effect of NO₃⁻ supplementation on MUP properties and reveal faster MUP duration after short-term NO₃⁻ supplementation which may have positive implications for skeletal muscle contractile performance.

Purpose: Since the effect of dietary nitrate (NO₃^‐) supplementation on rugby performance is unclear, the aim of the present study was to determine the effect of acute NO₃^‐ supplementation, on the modified Yo‐Yo intermittent recovery level 1 (IR1) performance test in trained male rugby players.Methods: In a randomised, counterbalanced, double‐blind, placebo‐controlled crossover design, 12 trained rugby union players performed two experimental trials three hours after supplementation of either 140 mL NO₃^‐‐rich (BRJ; ∼12.8 mmol NO₃^‐) or NO₃^‐‐depleted (PLA) BRJ. After blood sampling, players performed the modified Yo‐Yo IR1 test. Countermovement jumps (CMJ) were also measured before (pre‐CMJ) and after (post‐CMJ) the prone Yo‐Yo IR1 test.Results: Plasma NO₃^‐ (BRJ: 570 ± 146 µM vs. PLA: 72 ± 23 µM) and nitrite (NO₂^‐) concentrations (BRJ: 320 ± 123 nM vs. PLA: 103 ± 57 nM) were increased after BRJ compared to PLA supplementation (both P < 0.001). Performance in the modified Yo‐Yo IR1 test did not differ between BRJ (542 ± 209 m) and PLA (498 ± 185 m, P = 0.3). The jump height in pre‐CMJ and in post‐CMJ were similar between trials (both P > 0.05).Conclusions: Acute BRJ supplementation increased plasma NO₃^‐ and NO₂^‐ concentrations but had no benefit on an intermittent running test that reflects the demands of rugby performance, and CMJ performances. The findings do not support acute high‐dose NO₃^‐ supplementation as an ergogenic aid to enhance physical performance in trained male rugby players.